What we know and what we need to know about the role of endogenous CCK in psychostimulant sensitization

Life Sciences

Volumn 73, Issue 6, 2003, Pages 643-654

  Beinfeld, Margery C ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Dopamine; GABA; Glutamate; Nucleus accumbens; Prefrontal cortex; Ventral tegmental area

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; AMPHETAMINE; CHOLECYSTOKININ; CHOLECYSTOKININ A RECEPTOR ANTAGONIST; CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; COCAINE; DEVAZEPIDE; DOPAMINE RECEPTOR BLOCKING AGENT;

AMYGDALOID NUCLEUS; ANIMAL BEHAVIOR; BRAIN CORTEX; CONFERENCE PAPER; DOPAMINE METABOLISM; DOPAMINE RELEASE; DOPAMINERGIC ACTIVITY; MESOLIMBIC DOPAMINERGIC SYSTEM; NEUROCHEMISTRY; NONHUMAN; RAT STRAIN; VENTRAL TEGMENTUM;

EID: 0037498478     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(03)00384-9     Document Type: Conference Paper

References (81)

1. Akimoto K., Hamamura T., Otsuki S. Subchronic cocaine treatment enhances cocaine-induced dopamine efflux, studied by in vivo intracerebral dialysis. Brain Res. 490:1989;339-344.
2. Beinfeld M.C., Connolly K., Pierce R.C. OLETF (Otsuka Long-Evans Tokushima Fatty) rats that lack the CCK 1 (A) receptor develop less behavioral sensitization to repeated cocaine treatment than wild type LETO (Long Evans Tokushima Otsuka) rats. Peptides. 22:2001;1285-1290.
3. Beinfeld M.C., Connolly K.J., Pierce R.C. Cocaine treatment increases extracellular cholecystokinin (CCK) in the nucleus accumbens shell of awake, freely moving rats, an effect that is enhanced in rats that are behaviorally sensitized to cocaine. J Neurochem. 81:2002;1021-1027.
4. Bunney B.S., Aghajanian G.K. Dopamine and norepinephrine innervated cells in the rat prefrontal cortex: pharmacological differentiation using microiontophoretic techniques. Life Sci. 19:1976;1783-1789.
5. Cador M., Bjijou Y., Stinus L. Evidence of a complete independence of the neurobiological substrates for the induction and expression of behavioral sensitization to amphetamine. Neuroscience. 65:1995;385-395.
6. Crawley J.N. Subtype-selective cholecystokinin receptor antagonists block cholecystokinin modulation of dopamine-mediated behaviors in the rat mesolimbic pathway. J. Neurosci. 12:1992;3380-3391.
7. Dauge V., Sebret A., Beslot F., Matsui T., Roques B.P. Behavioral profile of CCK2 receptor-deficient mice. Neuropsychopharmacology. 25:2001;690-698.
8. DeSousa N.J., Wunderlich G.R., De Cabo C., Vaccarino F.J. The expression of behavioral sensitization to amphetamine: role of CCK(A) receptors. Pharmacol. Biochem. Behav. 62:1999;31-37.
9. Dougherty G.G. Jr., Ellinwood E.H. Jr. Chronic D-amphetamine in nucleus accumbens: lack of tolerance or reverse tolerance of locomotor activity. Life Sci. 28:1981;2295-2298.
10. Fallon J.H., Moore R.Y. Catecholamine innervation of the basal forebrain. IV. Topography of the dopamine projection to the basal forebrain and neostriatum. J. Comp Neurol. 180:1978;545-580.
11. Feifel D., Priebe K., Shilling P.D. Startle and sensorimotor gating in rats lacking CCK-A receptors. Neuropsychopharmacology. 24:2001;663-670.
12. Gerhardt G.A., Friedemann M., Brodie M.S., Vickroy T.W., Gratton A.P., Hoffer B.J., Rose G.M. The effects of cholecystokinin (CCK-8) on dopamine-containing nerve terminals in the caudate nucleus and nucleus accumbens of the anesthetized rat: an in vivo electrochemical study. Brain Res. 499:1989;157-163.
13. Grace A.A., Bunney B.S. The control of firing pattern in nigral dopamine neurons: single spike firing. J Neurosci. 4:1984;2866-2876.
14. Groenewegen H.J., Berendse H.W., Haber S.N. Organization of the output of the ventral striatopallidal system in the rat: ventral pallidal efferents. Neuroscience. 57:1993;113-142.
15. Hamilton M.E., Freeman A.S. Effects of administration of cholecystokinin into the VTA on DA overflow in nucleus accumbens and amygdala of freely moving rats. Brain Res. 688:1995;134-142.
16. Hamilton M.E., Redondo J.L., Freeman A.S. Overflow of dopamine and cholecystokinin in rat nucleus accumbens in response to acute drug administration. Synapse. 38:2000;238-242.
17. Heimer L., Harlan R.E., Alheid G.F., Garcia M.M., DeOlmos J. Substantia innominata: a notion which impedes clinical-anatomical correlations in neuropsychiatric disorders. Neuroscience. 76:1997;957-1006.
18. Heimer L., Zahm D.S., Churchill L., Kalivas P.W., Wohltmann C. Specificity in the projection patterns of accumbal core and shell in the rat. Neuroscience. 41:1991;89-125.
19. B receptor mechanisms to individual differences in amphetamine-induced locomotion. Pharmacol. Biochem. Behav. 48:1994;1019-1024.
20. Hitzemann R., Wu J., Hom D., Loh H. Brain locations controlling the behavioral effects of chronic amphetamine intoxication. Psychopharmacology (Berl). 72:1980;93-101.
21. Hokfelt T., Rehfeld J.F., Skirboll L., Ivemark B., Goldstein M., Markey K. Evidence for coexistence of dopamine and CCK in mesolimbic neurons. Nature. 285:1980;474-478.
22. Hokfelt T., Skirboll L., Rehfeld J.F., Goldstein M., Markey K., Dann O. A subpopulation of mesencephalic dopamine neurons projecting to limbic areas contain a cholecystokinin-like peptide:evidence from immunocytochemistry combined with retrograde tracing. Neurosci. 5:1980;2093-2124.
23. Hooks M.S., Duffy P., Striplin C., Kalivas P.W. Behavioral and neurochemical sensitization following cocaine self- administration. Psychopharmacology (Berl). 115:1994;265-272.
24. Hurd Y.L., Lindefors N., Brodin E., Brené S., Persson H., Ungerstedt U., Hokfelt T. Amphetamine regulation of mesolimbic dopamine/cholecystokinin neurotransmission. Brain Res. 578:1992;317-326.
25. A receptor involvement in the acquisition of conditioned activity produced by cocaine in rats. Brain Res. 763:1997;93-102.
26. Kalivas P.W., Alesdatter J.E. Involvement of N-methyl-D-Aspartate receptor stimulation in the ventral tegmental area and amygdala in behavioral sensitization to cocaine. J. Pharmacol. Exp. Ther. 267:1993;486-495.
27. Kalivas P.W., Duffy P. Time course of extracellular dopamine and behavioral sensitization to cocaine. I. Dopamine axon terminals. J. Neurosci. 13:1993;266-275.
28. Kalivas P.W., Duffy P. Repeated cocaine administration alters extracellular glutamate in the ventral tegmental area. J. Neurochem. 70:1998;1497-1502.
29. Kalivas P.W., Stewart J. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res. Rev. 16:1991;223-244.
30. Kalivas P.W., Weber B. Amphetamine injection into the ventral mesencephalon sensitizes rats to peripheral amphetamine and cocaine. J. Pharmacol. Exp. Ther. 245:1988;1095-1102.
31. Karler R., Calder L.D., Chaudhry I.A., Turkanis S.A. Blockade of "reverse tolerance" to cocaine and amphetamine by MK-801. Life Sci. 45:1989;599-606.
32. Karler R., Chaudhry I.A., Calder L.D., Turkanis S.A. Amphetamine behavioral sensitization and the excitatory amino acids. Brain Res. 537:1990;76-82.
33. Klitenick M.A., DeWitte P., Kalivas P.W. Regulation of somatodendritic dopamine release in the ventral tegmental area by opioids and GABA: an in vivo microdialysis study. J Neurosci. 12:1992;2623-2632.
34. Kobayashi S., Ohta M., Miyasaka K., Funakoshi A. Decrease in exploratory behavior in naturally occurring cholecystokinin (CCK)-A receptor gene knockout rats. Neurosci. Lett. 214:1996;61-64.
35. Koks S., Volke V., Veraksits A., Runkorg K., Sillat T., Abramov U., Bourin M., Huotari M., Mannisto P.T., Matsui T., Vasar E. Cholecystokinin2 receptor-deficient mice display altered function of brain dopaminergic system. Psychopharmacology (Berl). 158:2001;198-204.
36. Kolta M.G., Shreve P., De S.V., Uretsky N.J. Time course of the development of the enhanced behavioral and biochemical responses to amphetamine after pretreatment with amphetamine. Neuropharmacology. 24:1985;823-829.
37. Koob G.F. Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends in Pharmacological Science. 13:1988;177-184.
38. Ladurelle N., Keller G., Roques B.P., Dauge V. Effects of CCK8 and of the CCKB-selective agonist BC264 on extracellular dopamine content in the anterior and posterior nucleus accumbens: a microdialysis study in freely moving rats. Brain Res. 628:1993;254-262.
39. Li Y., Wolf M.E. Ibotenic acid lesions of prefrontal cortex do not prevent expression of behavioral sensitization to amphetamine. Behav. Brain Res. 84:1997;285-289.
40. Lodge D.J., Lawrence A.J. Comparative analysis of the central CCK system in Fawn Hooded and Wistar Kyoto rats: extended localisation of CCK-A receptors throughout the rat brain using a novel radioligand. Regul. Pept. 99:2001;191-201.
41. Lodge D.J., Short J.L., Mercer L.D., Beart P.M., Lawrence A.J. CCK/dopamine interactions in Fawn-Hooded and Wistar-Kyoto rat brain. Peptides. 21:2000;379-386.
42. Maidment N.T., Villafranca N.P. Persistence of the releasable pool of CCK in the rat nucleus accumbens and caudate-putamen following lesions of the midbrain. Brain Res. 747:1997;290-296.
43. Marshall F.H., Barnes S., Hughes J., Woodruff G.N., Hunter J.C. Cholecsytokinin modulates the release of dopamine from the anterior and posterior nucleus accumbens by two different mechanims. J. Neurochem. 56:1991;917-922.
44. A receptor. Neurosci. Lett. 225:1997;97-100.
45. Mercer L.D., Le V.Q., Nunan J., Jones N.M., Beart P.M. Direct visualization of cholecystokinin subtype2 receptors in rat central nervous system using anti-peptide antibodies. Neurosci. Lett. 293:2000;167-170.
46. Meyer D.K., Beinfeld M.C., Brownstein M.J. Origin of cholecystokinin containin fibers in the rat caudatoputamen. Science. 215:1982;187-188.
47. Morino P., Herrera-Marschitz M., Castel M.N., Ungerstedt U., Varro A., Dockray G., Hökfelt T. Cholecystokinin in cortico-striatal neurons in the rat: Immunohistochemical studies at the light and electron microscopical level. Eur. J. Neurosci. 6:1994;681-692.
48. Morino P., Herrera-Marschitz M., Meana J.J., Ungerstedt U., Hokfelt T. Immunohistochemical evidence for a crossed cholecystokinin corticostriatal pathway in the rat. Neurosci. Lett. 148:1992;133-136.
49. Morino P., Mascagni F., McDonald A., Hökfelt T. Cholecystokinin corticostriatal pathway in the rat: Evidence for bilateral origin from medial prefrontal cortical areas. Neuroscience. 59:1994;939-952.
50. Noble F., Wank S.A., Crawley J.N., Bradwejn J., Seroogy K.B., Hamon M., Roques B.P. International Union of Pharmacology. XXI. Structure, distribution, and functions of cholecystokinin receptors. Pharmacol. Rev. 51:1999;745-781.
51. Nomoto S., Miyake M., Ohta M., Funakoshi A., Miyasaka K. Impaired learning and memory in OLETF rats without cholecystokinin (CCK)-A receptor. Physiol Behav. 66:1999;869-872.
52. Parsons L.H., Justice J.B. Jr. Serotonin and dopamine sensitization in the nucleus accumbens, ventral tegmental area, and dorsal raphe nucleus following repeated cocaine administration. J. Neurochem. 61:1993;1611-1619.
53. Pettit H.O., Pan H.T., Parsons L.H., JusticeJr J.B. Extracellular concentrations of cocaine and dopamine are enhanced during chronic cocaine administration. J. Neurochem. 55:1990;798-804.
54. Phillips A.G., Di Ciano P. Behavioral sensitization is induced by intravenous self-administration of cocaine by rats. Psychopharmacology (Berl). 124:1996;279-281.
55. Pierce R.C., Bell K., Duffy P., Kalivas P.W. Repeated cocaine augments excitatory amino acid transmission in the nucleus accumbens only in rats having developed behavioral sensitization. J. Neurosci. 16:1996;1550-1560.
56. Pierce R.C., Kalivas P.W. A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res. Brain Res. Rev. 25:1997;192-216.
57. Pierce R.C., Kalivas P.W. Repeated cocaine modifies the mechanism by which amphetamine releases dopamine. J. Neurosci. 17:1997;3254-3261.
58. Pierce R.C., Kalivas P.W. Amphetamine produces sensitized increases in locomotion and extracellular dopamine preferentially in the nucleus accumbens shell of rats administered repeated cocaine. J. Pharmacol. Exp. Ther. 275:1998;1019-1029.
59. Pierce R.C., Reeder D.C., Hicks J., Morgan Z.R., Kalivas P.W. Ibotenic acid lesions of the dorsal prefrontal cortex disrupt the expression of behavioral sensitization to cocaine. Neuroscience. 82:1998;1103-1114.
60. Prasad B.M., Hochstatter T., Sorg B.A. Expression of cocaine sensitization: regulation by the medial prefrontal cortex. Neuroscience. 88:1999;765-774.
61. Reid M.S., Berger S.P. Evidence for sensitization of cocaine-induced nucleus accumbens glutamate release. Neuroreport. 7:1996;1325-1329.
62. Reum T., Fink H., Marsden C.A., Morgenstern R. Extracellular dopamine in the anterior nucleus accumbens is distinctly affected by ventral tegmental area administration of cholecystokinin and apomorphine: data from in vivo voltammetry. Neuropeptides. 32:1998;161-166.
63. Reum T., Schafer U., Marsden C.A., Fink H., Morgenstern R. Cholecystokinin increases extracellular dopamine overflow in the anterior nucleus accumbens via CCK(B) receptors in the VTA assessed by in vivo voltammetry. Neuropeptides. 31:1997;82-88.
64. Robinson T.E., Becker J.B. Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res. 396:1986;157-198.
65. Robinson T.E., Jurson P.A., Bennett J.A., Bentgen K.M. Persistent sensitization of dopamine neurotransmission in ventral striatum (nucleus accumbens) produced by prior experience with (+)- amphetamine: a microdialysis study in freely moving rats. Brain Res. 462:1988;211-222.
66. Schenk S., Valadez A., McNamara C., House D.T., Higley D., Bankson M.G., Gibbs S., Horger B.A. Development and expression of sensitization to cocaine's reinforcing properties: role of NMDA receptors. Psychopharmacology (Berl). 111:1993;332-338.
67. Seutin V., Johnson S.W., North R.A. Effect of dopamine and baclofen on N-methyl-D-aspartate-induced burst firing in rat ventral tegmental neurons. Neuroscience. 58:1994;201-206.
68. Sorg B.A., Davidson D.L., Kalivas P.W., Prasad B.M. Repeated daily cocaine alters subsequent cocaine-induced increase of extracellular dopamine in the medial prefrontal cortex. J. Pharmacol. Exp. Ther. 281:1997;54-61.
69. Stewart J., Druhan J.P. Development of both conditioning and sensitization of the behavioral activating effects of amphetamine is blocked by the non-competitive NMDA receptor antagonist, MK-801. Psychopharmacology (Berl). 110:1993;125-132.
70. Takiguchi S., Takata Y., Funakoshi A., Miyasaka K., Kataoka K., Fujimura Y., Goto T., Kono A. Disrupted cholecystokinin type-A receptor (CCKAR) gene in OLETF rats. Gene. 197:1997;169-175.
71. Vanderschuren L.J.M.J., Kalivas P.W. Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology (Berl). 151:2000;99-120.
72. Vezina P., Stewart J. Amphetamine administered to the ventral tegmental area but not to the nucleus accumbens sensitizes rats to systemic morphine: lack of conditioned effects. Brain Res. 516:1990;99-106.
73. White F.J., Hu X.T., Zhang X.F., Wolf M.E. Repeated administration of cocaine or amphetamine alters neuronal responses to glutamate in the mesoaccumbens dopamine system. J. Pharmacol. Exp. Ther. 273:1995;445-454.
74. Williams G.V., Goldman-Rakic P.S. Modulation of memory fields by dopamine D1 receptors in prefrontal cortex. Nature. 376:1995;572-575.
75. Wise R.A., Bozarth M.A. A psychomotor stimulant theory of addiction. Psychol. Rev. 94:1987;469-492.
76. Wolf M.E., Khansa M.R. Repeated administration of MK-801 produces sensitization to its own locomotor stimulant effects but blocks sensitization to amphetamine. Brain Res. 562:1991;164-168.
77. Wolf M.E., White F.J., Nassar R., Brooderson R.J., Khansa M.R. Differential development of autoreceptor subsensitivity and enhanced dopamine release during amphetamine sensitization. J. Pharmacol. Exp. Ther. 264:1993;249-255.
78. Wunderlich G.R., Bush D.E., Vaccarino F.J. Intra-nucleus accumbens microinjection of PD-140,548 A CCKa antagonist attenuates the locomotor response to amphetamine in chronically restrained animals. Society for Neuroscience Abstracts. 2:2000;1771.
79. Wunderlich G.R., DeSousa N.J., Vaccarino F.J. Cholecystokinin modulates both the development and expression of behavioral sensitization to amphetamine in the rat. Psychopharmacology. 151:2000;283-290.
80. You Z.B., Tzschentke T.M., Brodin E., Wise R.A. Electrical stimulation of the prefrontal cortex increases cholecystokinin, glutamate, and dopamine release in the nucleus accumbens: an in vivo microdialysis study in freely moving rats. J. Neurosci. 18:1998;6492-6500.
81. Zaborsky L., Alheid G.F., Beinfeld M.C., Eiden L.E., Heimer L., Palkovits M. Cholecystokinin innervation of the ventral striatum: a morphological and radioimmunological study. Neuroscience J. 14:1985;427-453.